Composition
- Active ingredients
- TACROLIMUS EQ 5MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TACROLIMUS EQ 5MG BASE · CapsuleANDA090509-003 · Prescription
- TACROLIMUS EQ 0.5MG BASE · CapsuleANDA090509-001 · Prescription
- TACROLIMUS EQ 1MG BASE · CapsuleANDA090509-002 · Prescription
- TACROLIMUS EQ 5MG BASE · CapsuleANDA210929-003 · Discontinued
- TACROLIMUS EQ 0.5MG BASE · CapsuleANDA210929-001 · Discontinued
- TACROLIMUS EQ 1MG BASE · CapsuleANDA210929-002 · Discontinued
- TACROLIMUS EQ 5MG BASE · CapsuleANDA206651-003 · Prescription
- TACROLIMUS EQ 0.5MG BASE · CapsuleANDA206651-001 · Prescription
- TACROLIMUS EQ 1MG BASE · CapsuleANDA206651-002 · Prescription
- TACROLIMUS EQ 5MG BASE · Capsule, extended releaseANDA215012-003 · Prescription
- TACROLIMUS EQ 0.5MG BASE · Capsule, extended releaseANDA215012-001 · Prescription
- TACROLIMUS EQ 1MG BASE · Capsule, extended releaseANDA215012-002 · Prescription
- TACROLIMUS EQ 5MG BASE · Capsule
At a glance
- Brand name
- Tacrolimus
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Heritage Pharma Avet
- Status
- Discontinued
- FDA approval
- 1 Jul 2010
- Application
- ANDA090402-001